Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (30396)

« Back to Publications

Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).

Lowe DM. et al, (2027), Lancet Microbe

Multi-objective optimisation of 3D-printed multilayer TPMS osteochondral scaffolds for enhanced mechanical and biological performance

Xu Y. et al, (2026), Virtual and Physical Prototyping, 21

Subharmonics are not an infallible safety metric for cavitation dynamics.

Wu Q. et al, (2026), Int J Hyperthermia, 43

Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with active psoriatic arthritis: 52-week results from the randomized, double-blind, placebo-controlled phase 3 POETYK PsA-1 trial

Coates L., (2026), Annals of the Rheumatic Diseases

Immunometabolic mechanisms across psoriatic disease: Linking psoriasis to psoriatic arthritis

Coates L. et al, (2026), Clinical Rheumatology

Psoriatic Arthritis and Obesity: A Review of Clinical Burden and Considerations for Comprehensive Care

Coates L., (2026), RMD Open

AlphaEarth Satellite Embeddings for Modelling Climate Sensitive Diseases Towards Global Health Resilience

Nazir U. and Sara K., (2026)

Efficacy and safety of upadacitinib in patients with psoriatic arthritis and exposure to one anti-TNF : post hoc analysis of SELECT-PsA 2

Coates L., (2026), RMD Open

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol

Brewer G. et al, (2026), Trials, 27

Assessing the Importance of Variation in Diagnostic Coding Among the Three Countries in the UK Biobank.

Clifton L. et al, (2026), Learn Health Syst, 10

Hospital costs attributable to further fracture, reoperation, and death during the first year following hip fracture in England : a nationwide cohort study.

Baji P. et al, (2026), Bone Joint J, 108-B, 952 - 960

Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL

Coates LC. et al, (2026), RMD Open, 20, e043855 - e043855

Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST

Coates LC. et al, (2026), Rheumatology

Optimal management of pyogenic flexor tenosynovitis of the hand: a cohort study

Hennessy M. et al, (2026), Journal of Hand and Microsurgery, 18

Threat assessment shapes neutrophil cell fate upon inflammasome activation.

Yow SJ. et al, (2026), Sci Adv, 12

Load More

1
2
3
4
5
6
7
...
»